(firstQuint)Epidemiology Study of Malaria Transmission Intensity in Africa.

 This study is a multicenter epidemiology study at centers that are participating in GSK's pivotal Phase III candidate malaria vaccine 110021 ( NCT00866619) trial and will involve 4 annual cross sectional surveys performed preferably at peak transmission.

 There will be no study vaccine administered in this epidemiology study.

.

 Epidemiology Study of Malaria Transmission Intensity in Africa@highlight

The aim of this epidemiology study is to characterize in a standardized way malaria transmission intensity at the clinical trial centers participating in study 110021 (NCT00866619).

